Three-year pooled data from the ALTERRA trials demonstrate that the Alterra Adaptive Prestent combined with the SAPIEN 3 THV is highly effective and safe for treating severe pulmonary regurgitation in patients with large right ventricular outflow tracts, showing sustained durability and low reintervention rates.